-
Kenya's economy faces climate change risks: World Bank
-
Amazon beats expectations with cloud and AI growth
-
Apple tops estimates in CEO Cook's final quarter, but shares fall
-
Blowout Microsoft results lift US stocks as oil retreats
-
Milei demands expulsion of foreigners expressing 'hate' against Argentina
-
'Beginning of the end': Relief but no party as French wildfire winds down
-
Italy's Po River valley on drought alert
-
Southern Europe 'becoming more flammable' in hotter climate, experts say
-
Prada profits pinched as growth hard to chase
-
Mammoth bones found on parched bed of Danube in Bulgaria
-
Stocks climb on earnings and rates, oil retreats
-
MEXC Lists Grvt (GRVT) with $60,000 Worth of GRVT and 10,000 USDT in Airdrop+ Rewards
-
US economic growth slows in second quarter, missing expectations
-
George and Amal Clooney flee French home due to wildfire
-
Russia adds Telegram founder Durov to 'terrorist' blacklist
-
MEXC Ventures Supports Alpha Arena's APAC Debut at Coinfest Bali
-
Stocks diverge on earnings, as oil steadies
-
AI data centre supplier Zhongji InnoLight slips on Hong Kong debut
-
Eurozone economy grows despite Middle East war
-
May, June heatwaves caused 2,877 extra deaths in England: govt
-
Singapore group will develop 'most promising' Ebola vaccine
-
BMW profit down a third as carmaker plans job cuts
-
Shell profit surges as Mideast war fuels oil prices
-
Seoul extends losses as most Asian markets drop, oil rises again
-
Car maker Stellantis says back in profit in second quarter
-
Gambling.com Group Is Now Grandstand
-
Samsung quarterly operating profit up 1,800% on AI boom
-
Meet the astronomer digging into the Milky Way's 'fossils'
-
South Korean stocks bounce after rout, oil holds gains on Mideast woes
-
AI data centre supplier Zhongji InnoLight falls on Hong Kong debut
-
South Korea's women web sleuths fight AI deepfake porn
-
Samsung operating profit up 1,800% in second quarter on AI boom
-
Anything but programmable: New cost-efficient EC-power-supply-series for the DIN rail by CAMTEC PS
-
Japanese population below 120 million for first time in decades
-
Meta misses profit expectations, sticks to massive AI spending
-
US actor Jared Leto denies latest accusations of sexual assault
-
Campari - king of the spritz - hopes to conquer American heartland
-
Danube drops to 'historic lows' as fresh heatwave hits
-
Air France-KLM and Lufthansa bid for Portugal's TAP airline
-
BTS pulls out of Grammys after Asian pop category introduction
-
Profits soar at Airbus as it delivers more planes
-
OpenAI says rogue AI agent attack hit other companies
-
Rheinmetall shares surge after armsmaker reports record profit
-
How an AFP beach snap became emblem of Europe's wildfire summer
-
FIFA hit by furious backlash over plans to sell stake in competitions
-
TRX Spot and Perpetuals Listing Launches on Backpack, Expanding Access to the TRON Ecosystem
-
MEXC Integrates World-Check to Fortify Institutional Grade Compliance Architecture
-
Nepal's tiger numbers climb 20 percent to estimated 429: survey
-
Spain returns wildfire evacuees as France braces for worsening weather
-
FIFA's plans to sell $4.2bn stake in its tournaments widely criticised
Morocco starts construction of anti-Covid vaccine plant
Morocco on Thursday inaugurated construction of an anti-Covid vaccine manufacturing plant in partnership with Swedish firm Recipharm, the official news agency MAP reported.
The factory to be known as Sensyo Pharmatech will produce vaccines against coronavirus and other diseases, with production expected to reach 116 million units in 2024, MAP said.
It was launched in Benslimane, a region of Morocco's economic hub Casablanca during a ceremony attended by King Mohammed VI, it said.
The plant will need investments of between 400-500 million euros ($445 million-$557 million).
It is aimed at ensuring vaccine "self-sufficiency" for the North African kingdom, MAP said.
Its goal is to make, between 2022 and 2025, "active substances for more than 20 vaccines, three of which would be against coronavirus... to cover 70 percent of the kingdom's needs and more than 60 percent of needs across Africa", the agency said.
Morocco is already producing the Chinese anti-Covid Sinopharm vaccine, with more than three million doses being made per month.
By next month it plans on producing five million doses and more than 20 million by the end of the year.
Home to 36 million inhabitants, Morocco is hoping that its vaccination drive will help eradicate Covid-19. More than 23 million people have already received a second dose against coronavirus, according to the health ministry.
Authorities hope to vaccinate 80 percent of the population with either Sinopharm or Pfizer-BioNTech.
In July, Recipharm said it had signed a memorandum of understanding with Morocco and a consortium of the country's leading banks to build a factory to produce vaccines and biotherapeutics in the kingdom.
As part of the deal, it said in a statement at the time, $500 million would be invested into the project by the Moroccan government and consortium.
"The investment is primarily to supply the African continent and help it gain vaccine sovereignty and access to future biotherapeutics," it said.
Y.Uduike--CPN